Hostname: page-component-669899f699-b58lm Total loading time: 0 Render date: 2025-05-05T00:05:44.676Z Has data issue: false hasContentIssue false
  • English
  • Français

Right ventricular outflow tract stenting in children with tetralogy of Fallot beyond one year of age: indications and immediate outcomes

Published online by Cambridge University Press:  26 December 2024

Shaad Abqari ,
Mohammad Moaaz Kidwai Open the ORCID record for Mohammad Moaaz Kidwai [Opens in a new window] ,
Mirza Mohammad Kamran Open the ORCID record for Mirza Mohammad Kamran [Opens in a new window] ,
Mohammad Azam Haseen  and
Shamayal Rabbani
Shaad Abqari*
Affiliation:
Department of Pediatrics, JNMCH, Aligarh Muslim University, Aligarh, Uttar Pradesh, India
Mohammad Moaaz Kidwai
Affiliation:
Department of Cardiology, JNMCH, Aligarh Muslim University, Aligarh, Uttar Pradesh, India
Mirza Mohammad Kamran
Affiliation:
Interdisciplinary Pediatric cardiac centre, JNMCH, Aligarh Muslim University, Aligarh, Uttar Pradesh, India
Mohammad Azam Haseen
Affiliation:
Department of CVTS, JNMCH, Aligarh Muslim University, Aligarh, Uttar Pradesh, India
Shamayal Rabbani
Affiliation:
Department of CVTS, JNMCH, Aligarh Muslim University, Aligarh, Uttar Pradesh, India
*
Corresponding author: Shaad Abqari; Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Right ventricular outflow tract stenting has emerged as a key palliative intervention for infants with tetralogy of Fallot who are not suitable candidates for complete repair. Although the Blalock-Taussig shunt remains the standard palliative approach for tetralogy of Fallot patients over one year of age, the potential of right ventricular outflow tract stenting in this older age group has not been widely explored. In this study, we present our experience with right ventricular outflow tract stenting in children beyond one year of age.

Methods and Results:

In this study, a total of 52 patients of tetralogy of Fallot who underwent palliative stenting of the right ventricular outflow tract from 2018 to 2022 were enrolled. Out of the 52 patients, 38 children were more than 1 year of age with a mean age of 4.82 ± 3.5 (1.5–13 years) and mean weight of 13.10 ± 7.0 (5.6–34) kgs. Most common indication was presence of unfavourable anatomy in 27 (71%) followed by presence of refractory spells in 14 (36.8%) patients. Stent embolisation was seen in one patient, while two patients developed features of pulmonary oedema and needed prolonged ventilatory support. There was no mortality seen in this study group.

Conclusion:

Our study has shown that right ventricular outflow tract stenting in children even beyond one year of age is technically feasible, with good immediate outcomes, especially in those who present with any complication, thus reducing the perioperative morbidity and mortality.

Keywords

right ventricular outflow tract stentingtetralogy of Fallotpulmonary arteryrisk factors
Type
Original Article
Information
Cardiology in the Young , Volume 35 , Issue 2 , February 2025 , pp. 393 - 398
Check for updates
Copyright
© The Author(s), 2025. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Gladman, G, McCrindle, BW, Williams, WG, Freedom, RM, Benson, LN. The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot’s tetralogy in the current era. J Thorac Cardiovasc Surg 1997; 114: 25–30.CrossRefGoogle ScholarPubMed
Petrucci, O, O’Brien, SM, Jacobs, ML, Jacobs, JP, Manning, PB, Eghtesady, P. Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure. Ann Thorac Surg 2011; 92: 642–651.CrossRefGoogle ScholarPubMed
Sandoval, JP, Chaturvedi, RR, Benson, L et al. Right ventricular outflow tract stenting in tetralogy of Fallot infants with risk factors for early primary repair. Circ Cardiovasc Interv 2016; 9: e003979. DOI: 10.1161/CIRCINTERVENTIONS.116.003979.CrossRefGoogle ScholarPubMed
Dohlen, G, Chaturvedi, RR, Benson, LN et al. Stenting of the right ventricular outflow tract in the symptomatic infant with tetralogy of Fallot. Heart 2009; 95: 142–147. DOI: 10.1136/hrt.2007.135723.CrossRefGoogle ScholarPubMed
Quandt, D, Penford, G, Ramchandani, B, Bhole, V, Mehta, C, Stumper, O. Stenting of the right ventricular outflow tract as primary palliation for Fallot-type lesions. J Congenit Cardiol 2017; 1: 3.CrossRefGoogle Scholar
Iyer, PU, Moreno, GE, Caneo, LF, Faiz, T, Shekerdemian, LS, Iyer, KS. Management of late presentation congenital heart disease. Cardiol Young 2017; 27: S31–9.CrossRefGoogle ScholarPubMed
Laurentius, A, Wiyono, L, Subali, AD, Siagian, SN. Evaluation of right ventricular outflow tract stenting as palliative treatment in severely cyanotic Tetralogy of Fallot: a systematic review and meta-analysis of observational studies. J Tehran Univ Heart Center 2021; 16: 135–146.Google ScholarPubMed
Linnane, N, Nasef, MA, McMahon, CJ et al. Right ventricular outflow tract stenting in symptomatic infants without the use of a long delivery sheath. Catheter Cardiovasc Interv 2021; 98: E275–E281.CrossRefGoogle ScholarPubMed
Prabhu, S, Mehra, S, Kanaparthi, S, Maiya, SS, Rao, S. Right ventricular outflow tract histology post-stenting and in-stent stenosis. Ann Pediatr Cardiol 2022; 15: 206–208.CrossRefGoogle ScholarPubMed
McElhinney, DB, Cheatham, JP, Jones, TK et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US melody valve trial. Circ Cardiovasc Interv 2011; 4: 602–614.CrossRefGoogle ScholarPubMed
Abqari, S. Right Ventricular Outflow Tract Stenting. Congenital Heart Defects: Recent Advances, 2022, 187.Google Scholar